Sign in
4

Changes in Ownership

Larimar Therapeutics, Inc. Filed Acc 0001062993-24-003312

Director bought 2,000 shares at $11.00 ($22,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
THOMAS FRANK E Director 2024-02-14 Purchase +2,000 $11.00 $22,000 2,000 D
Open-market purchases · 2,000 sh · avg $11.00 · $22,000
Loading xslF345X05/form4.xml…